Kiepe Daniela, Ulinski Tim, Powell David R, Durham Susan K, Mehls Otto, Tönshoff Burkhard
Division of Pediatric Nephrology, University Children's Hospital, Heidelberg, Germany.
Kidney Int. 2002 Nov;62(5):1591-600. doi: 10.1046/j.1523-1755.2002.00603.x.
In children with chronic renal failure (CRF), impairment of longitudinal growth is in part due to excess amounts of circulating high-affinity insulin-like growth factor binding proteins (IGFBPs) that might decrease or prevent insulin-like growth factor (IGF) binding to its signaling receptor. However, it appears from the clinical studies that various IGFBPs may have contrasting effects on longitudinal growth. Because of the potential importance of the IGFBPs as modulators of longitudinal growth in pediatric CRF, the aim of the present study was to investigate the biological effects of IGFBP-1, -2, -3, and -6 on cultured growth plate chondrocytes that express the type 1 IGF receptor.
The effects of exogenous IGFBPs on IGF-independent and IGF-dependent proliferation of rat growth plate chondrocytes in primary culture were investigated. Proliferation was assessed by colony formation of agarose-stabilized long-term suspension cultures and by the [3H]thymidine assay. The effects of IGFBPs on IGF-I binding and the binding of IGFBPs to chondrocytes were assessed by binding studies with radiolabeled proteins in monolayer culture.
Intact IGFBP-1, IGFBP-2 and IGFBP-6 inhibited in equimolar concentration the IGF-I- and IGF-II-stimulated DNA synthesis and cell proliferation, whereas the biological activity of IGFBP-3 was complex. It had an IGF-independent antiproliferative effect and also inhibited IGF-dependent chondrocyte proliferation under coincubation conditions, whereas under preincubation conditions IGFBP-3 enhanced IGF-I-responsiveness. Studies on the mechanism by which IGFBP-3 potentiated IGF activity demonstrated that under preincubation conditions IGFBP-3 is capable to associate with the cell membrane and to facilitate IGF-I cell surface binding.
Intact IGFBP-1, IGFBP-2 and IGFBP-6 act exclusively as growth inhibitors on IGF-dependent proliferation of growth plate chondrocytes. IGFBP-3, however, can either inhibit IGF-independent and IGF-dependent cell proliferation, or enhance IGF responsiveness of chondrocytes dependent on the temporal relationship to the IGF exposure.
在慢性肾衰竭(CRF)儿童中,纵向生长受损部分归因于循环中高亲和力胰岛素样生长因子结合蛋白(IGFBPs)过量,这些蛋白可能会减少或阻止胰岛素样生长因子(IGF)与其信号受体结合。然而,临床研究表明,各种IGFBPs对纵向生长可能有相反的作用。鉴于IGFBPs作为小儿CRF纵向生长调节因子的潜在重要性,本研究旨在探讨IGFBP-1、-2、-3和-6对表达1型IGF受体的培养生长板软骨细胞的生物学效应。
研究外源性IGFBPs对原代培养的大鼠生长板软骨细胞不依赖IGF和依赖IGF增殖的影响。通过琼脂糖稳定的长期悬浮培养中的集落形成和[3H]胸苷测定评估增殖。通过单层培养中放射性标记蛋白的结合研究评估IGFBPs对IGF-I结合以及IGFBPs与软骨细胞结合的影响。
完整的IGFBP-1、IGFBP-2和IGFBP-6以等摩尔浓度抑制IGF-I和IGF-II刺激的DNA合成及细胞增殖,而IGFBP-3的生物学活性较为复杂。它具有不依赖IGF的抗增殖作用,在共孵育条件下也抑制依赖IGF的软骨细胞增殖,而在预孵育条件下,IGFBP-3增强IGF-I反应性。关于IGFBP-3增强IGF活性机制的研究表明,在预孵育条件下,IGFBP-3能够与细胞膜结合并促进IGF-I在细胞表面的结合。
完整的IGFBP-1、IGFBP-2和IGFBP-6仅对生长板软骨细胞依赖IGF的增殖起生长抑制作用。然而,IGFBP-3根据与IGF暴露的时间关系,既可以抑制不依赖IGF和依赖IGF的细胞增殖,也可以增强软骨细胞对IGF的反应性。